Endurant, Endurant II and Endurant IIs Stent Graft System
FDA premarket approval P100021/S079 · decided 2020-01-09
Approval details
- PMA number
- P100021
- Supplement
- S079
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- Endurant, Endurant II and Endurant IIs Stent Graft System
- Generic name
- SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
- Applicant
- Medtronic Vascular
- Date received
- 2020-01-08
- Decision date
- 2020-01-09
- Days to decision
- 1 days
- Decision code
- OK30
- Product code
- MIH
- Advisory committee
- Cardiovascular
- Expedited review
- No
- Location
- Santa Rosa, CA
- Statement
- Changes to a supplier's manufacturing site, tools, and aids used in the manufacturing of a delivery system component used in the Endurant, Endurant II, and Endurant IIs.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.